Name of Drug Classification and
(Dosage, Route, Frequency, Mechanism of Action
Timing)
Generic Name: Classification:
The chemical classification of
Meropenem meropenem anhydrous
isCarbapenems. Meropenem
Brand Name: is a carbapenem antibiotic
with broad spectrum of
Merrem activity that is
administered intravenouslyan
Dosage:
d used for severe bacterial
infections due to sensitive
500 mg 1 tab
agents.
Route:
Mechanism of Action:
Meropenem
Oral
is bactericidal except
Frequency: against Listeria
monocytogenes, where it
Q8H is bacteriostatic. It inhibits
bacterial wall synthesis like
Timing: other β-lactam antibiotics. In
contrast to other beta-
4 am, 12 pm, 8 pm
lactams, it is highly resistant
to degradation by β-
lactamases or
cephalosporinases..
Indication and Side Effects or Adverse
Contraindication
Indication:
Prescribed for bacterial
infections like skin and skin
structure infections ,bacterial
meningitis ,serious
nosocomial infections like
septicaemia, febrile
neutropenia ,intra abdominal
and pelvic infections .The
medication inhibits cell wall
synthesis in bacteria ,and
thereby leading to cell death.
Contraindication:
Contraindicated with
hypersensitivity to
carbapenem antibiotics
Nursing Responsibilities
Reactions
allergic reaction (difficulty
breathing; closing of the
throat; swelling of the lips,
tongue, or face; or hives);
seizures; severe or watery
diarrhea; a skin rash;
unusual tiredness or
weakness; or unusual
bleeding or bruising; nausea
or vomiting; diarrhea or
constipation; headache; or
soreness, redness, or mild
swelling at the injection site
1. Right Drug/Medication
2. Right Client/Patient
3. Right Route
4. Right Dose
5. Right Frequency/Time
6. Right Assessment
7. Right Approach
8. Right Education
9. Right Evaluation
10. Right Documentation
11. Right to Refuse
12. Right Principle of Care
13. Right Prescription
14. Right Nurse Clinician
Assessment & Drug Effects
Lab tests: Perform C&S tests prior
to therapy. Monitor periodically
liver and kidney function.
Determine history of
hypersensitivity reactions to other
beta-lactams, cephalosporins,
penicillins, or other drugs.
Discontinue drug and immediately
report S&S of hypersensitivity (see
Appendix F).
Report S&S of super infection or
pseudomembranous colitis (see
Appendix F).